The untapped potential of ballistographic technology in behavioural sleep medicine.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41882337.
- Also identified by DOI 10.1038/s41746-026-02350-w and PMC identifier 13018190.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Insomnia is the most prevalent sleep disorder globally, for which Cognitive Behavior Therapy for Insomnia (CBT-I) is the first-line treatment. We argue that under-mattress ballistography has the potential to enhance CBT-I delivery by providing treatment-relevant sleep metrics – sleep onset latency, wake after sleep onset, and sleep efficiency, with fewer limitations than polysomnography/actigraphy and consumer-wearable technologies. Validation studies show strong timing accuracy and acceptable sleep–wake classification. Integrating these metrics with CBT-I may improve decision-making, adherence, and outcomes. Future pragmatic trials and validation studies in psychiatric populations are needed.